BCM Gastroenterology Grand Rounds - References
Previous


    1. Reinus JF. Vascular ectasias and diverticulosis. Common causes of lower intestinal bleeding. Gastroenterol Clin North Am 1994;23:1-20.
    2. Vernava AM.  Lower gastrointestinal bleeding. Dis Colon Rectum 1997;40:846-58
    3.  Foutch PG.  Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. Am J Gastroenterol 1995;90:564-7
    4. Richter JM. Angiodysplasia. Natural history and efficacy of therapeutic interventions. Dig Dis Sci 1989;34:1542-6.
    5.  Siple  JF.  Use of estrogen therapy in a patient with gastrointestinal bleeding secondary to arteriovenous malformations. Ann Pharmacother 1997;31:1311-4
    6. Vase P.  Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial. Acta Med Scand 1981;209:393-6.
    7. Van Cutsem E. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 1990;335:953-5.
    8. Van Cutsem E. Oestrogen-progesterone, a new therapy of bleeding gastrointestinal vascular malformations.  Acta Gastroenterol 1993;56:2-10
    9. Lewis BS. Does hormonal therapy have any benefit for bleeding angiodysplasia? J Clin Gastroenterol 1992;15:99-103.
    10.  Nardone G.  The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999;13:1429-36
    11. Gurbuz AK.  Premarin-induced ischemic colitis. J Clin Gastroenterol 1994;19:108-11

    12.Fogel R, Valdivia EA. Bleeding Angiodysplasia of the Colon. Curr Treat Options Gastroenterol. 2002 Jun;5(3):225-230.
    13.Hodgson H. Hormonal therapy for gastrointestinal angiodysplasia.Lancet. 2002 May 11;359(9318):1630-1.
    14. F. Junquera, F. Feu, M. Papo et al., A multicenter, randomised, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 121 (2001), pp. 1073¯1079.


     

     

     


Previous